Concepedia

Author

Dirk Elling

Charité - Universitätsmedizin Berlin

Also Known As

D Elling, D. Elling, Dirk Elling

124

Publications

962

Citations

17

H-Index

29

Concepts

All Affiliations

Charité - Universitätsmedizin BerlinSana Klinikum LichtenbergHelios Hospital Berlin-BuchStiftung Oskar Helene HeimGoethe University Frankfurt
DE

About

Dirk Elling is an author at Charité - Universitätsmedizin Berlin specializing in oncology, medicine, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

12

13

319

2

Health Sciences

5

5

102

3

Obstetrics

3

3

96

4

Pathology

2

2

35

5

Nursing

1

1

13

Dirk Elling

×

24

Publications

805

Citations

17

H-Index

YearCitations

Granulosa cell tumor of the ovary: 10 years follow-up data of 65 patients.

Jalid Sehouli, Frank Drescher, Alexander Mustea,

PubMed

2004

122

German Adjuvant Intergroup Node-Positive Study: A Phase III Trial to Compare Oral Ibandronate Versus Observation in Patients With High-Risk Early Breast Cancer

Gϋnter von Minckwitz, Volker Möbus, Andreas Schneeweiß,

Journal of Clinical Oncology

2013

99

Randomised trial: survival benefit and safety of adjuvant dose-dense chemotherapy for node-positive breast cancer

Sherko Kümmel, J. Krocker, A. Kohls,

British Journal of Cancer

2006

53

Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

Sibylle Loibl, Gϋnter von Minckwitz, Nadia Harbeck,

Breast Cancer Research

2008

49

Transvaginal video-assisted cholecystectomy in clinical practice

Matthias Federlein, Dietmar Borchert, Verena Müller,

Surgical Endoscopy

2010

44

Randomized Phase III Trial of Sequential Adjuvant Chemoradiotherapy With or Without Erythropoietin Alfa in Patients With High-Risk Cervical Cancer: Results of the NOGGO-AGO Intergroup Study

Jens‐Uwe Blohmer, Stefan Paepke, Jalid Sehouli,

Journal of Clinical Oncology

2011

43

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

Peter Schmid, J. Krocker, C. Jehn,

Annals of Oncology

2005

38

Side Effects of Standard Adjuvant and Neoadjuvant Chemotherapy Regimens According to Age Groups in Primary Breast Cancer

Mattea Reinisch, Gϋnter von Minckwitz, Nadia Harbeck,

Breast Care

2013

37

Weekly paclitaxel and carboplatin (PC-W) for patients with primary advanced ovarian cancer: results of a multicenter phase-II study of the NOGGO

Jalid Sehouli, Dirk Stengel, Alexander Mustea,

Cancer Chemotherapy and Pharmacology

2007

33

A phase II study of topotecan plus gemcitabine in the treatment of patients with relapsed ovarian cancer after failure of first-line chemotherapy

Jalid Sehouli, Dirk Stengel, G. Oskay,

Annals of Oncology

2002

33

Page 1